Cubist Systematic Strategies’s Enanta Pharmaceuticals ENTA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-20,255
Closed -$116K 1693
2024
Q4
$116K Sell
20,255
-2,665
-12% -$15.3K ﹤0.01% 1258
2024
Q3
$237K Sell
22,920
-22,430
-49% -$232K ﹤0.01% 1122
2024
Q2
$588K Buy
45,350
+18,003
+66% +$233K ﹤0.01% 889
2024
Q1
$477K Sell
27,347
-55,420
-67% -$968K ﹤0.01% 1402
2023
Q4
$779K Buy
82,767
+14,221
+21% +$134K 0.01% 1219
2023
Q3
$766K Sell
68,546
-31,942
-32% -$357K 0.01% 1131
2023
Q2
$2.15M Buy
100,488
+64,217
+177% +$1.37M 0.01% 857
2023
Q1
$1.47M Buy
36,271
+1,447
+4% +$58.5K 0.01% 1276
2022
Q4
$1.62M Sell
34,824
-5,499
-14% -$256K 0.01% 1441
2022
Q3
$2.09M Buy
40,323
+2,900
+8% +$150K 0.01% 1556
2022
Q2
$1.77M Buy
37,423
+33,227
+792% +$1.57M 0.01% 1675
2022
Q1
$299K Sell
4,196
-42,655
-91% -$3.04M ﹤0.01% 2822
2021
Q4
$3.5M Buy
46,851
+35,438
+311% +$2.65M 0.03% 905
2021
Q3
$648K Buy
+11,413
New +$648K 0.01% 1847
2021
Q2
Sell
-4,072
Closed -$201K 2957
2021
Q1
$201K Buy
+4,072
New +$201K ﹤0.01% 2474
2020
Q4
Sell
-14,316
Closed -$655K 2592
2020
Q3
$655K Buy
14,316
+4,397
+44% +$201K 0.01% 1581
2020
Q2
$498K Buy
9,919
+4,211
+74% +$211K 0.01% 1592
2020
Q1
$294K Sell
5,708
-2,313
-29% -$119K 0.01% 1532
2019
Q4
$496K Buy
8,021
+2,433
+44% +$150K 0.01% 1560
2019
Q3
$336K Buy
5,588
+685
+14% +$41.2K 0.01% 1497
2019
Q2
$414K Buy
4,903
+1,175
+32% +$99.2K 0.01% 1606
2019
Q1
$356K Buy
3,728
+407
+12% +$38.9K 0.01% 1398
2018
Q4
$235K Buy
+3,321
New +$235K 0.01% 1433
2018
Q3
Sell
-4,661
Closed -$540K 1922
2018
Q2
$540K Sell
4,661
-1,189
-20% -$138K 0.03% 756
2018
Q1
$473K Buy
5,850
+1,243
+27% +$101K 0.03% 828
2017
Q4
$270K Buy
+4,607
New +$270K 0.01% 1328
2017
Q2
Sell
-300
Closed -$9K 1726
2017
Q1
$9K Buy
+300
New +$9K ﹤0.01% 1568